See how our Double Helix sponsor, Johnson & Johnson, is participating in BIO Digital Week!
Sponsored Sessions:
Science on the Front Lines & on the Front Page
Monday, June 8 at 1:00 PM - 2:15 PM PDT
Join this panel of policy makers and science journalists as they discuss ways to make science more transparent and inclusive, and what strategies are need to boost public trust and engagement in science.
[Special 3-Part Plenary Session] A Way Forward: Winning the War on COVID through Vaccines
Tuesday, June 9 at 11:00 AM - 1:30 PM PDT
The long-term solution to the pandemic is the availability of vaccines. Yet the development of a vaccine is complex, especially during a global pandemic of an unknown pathogen. Even so, many vaccine developers moved swiftly, using platform technologies to go from genetic sequence data to vaccine candidates in a few weeks. This three-part plenary session facilitated by Phyllis Arthur, Vice President, Infectious Diseases and Diagnostics Policy, BIO, will focus on the novel science of vaccines in development as well as the challenges of clinical trials, manufacturing scale-up and global implementation.
How COVID-19 Has Impacted the Global Psyche
Wednesday, June 10 at 1:00 PM - 2:15 PM PDT
Join this panel of mental health, advocacy and policy experts to discuss the actions that must be undertaken to advance prevention-focused mental health care and resilience as we go through and emerge from the COVID-19 pandemic, and the importance of advocacy in mental health.
Thought Leaders:
Sharon Chan, MBA, MPH, D. Phil
HEAD JLABS @ SHANGHAI, JOHNSON & JOHNSON INNOVATION
Speaking on: How an Innovation Ecosystem Enables Growth During Times of Crisis and Beyond
Robert DeBerardine
CHIEF INTELLECTUAL PROPERTY COUNSEL, JOHNSON & JOHNSON
Speaking on: Patents in the Time of Covid-19: Innovation and Access to Medicine now and for the future
Nicholas Franco
EVP & CHIEF BUSINESS DEVELOPMENT OFFICER, ACTELION PHARMACEUTICALS LTD, A JANSSEN PHARMACEUTICAL COMPANY OF JOHNSON & JOHNSON
Speaking on: Is It Time to Reconsider M&A’s Role in Portfolio Building?
William Hait, MD, PhD
GLOBAL HEAD, JOHNSON & JOHNSON EXTERNAL INNOVATION, JOHNSON & JOHNSON
Speaking on: Nature Biotechnology and Scientific American WORLDVIEW: Whiplash! How COVID-19 Will Radically Change Biomedical R&D Across the Globe
Seema Kumar
VICE PRESIDENT OF INNOVATION, GLOBAL HEALTH AND POLICY COMMUNICATION, JOHNSON & JOHNSON INNOVATION
Speaking on: Science on the Front Lines & on the Front Page, The BioGENEius and GenePool Challenges, and How COVID-19 Has Impacted the Global Psyche
Mathai Mammen, MD, PhD
GLOBAL HEAD, RESEARCH & DEVELOPMENT, JANSSEN PHARMACEUTICAL COMPANIES OF JOHNSON & JOHNSON
Speaking on: Fireside Chat with Mathai Mammen, MD, PhD, Global Head, Research and Development, Janssen Pharmaceutical Companies of Johnson & Johnson
Husseini Manji, MD, FRCP (C)
GLOBAL THERAPEUTIC AREA HEAD, NEUROSCIENCE, JOHNSON & JOHNSON
Speaking on: How COVID-19 Has Impacted the Global Psyche
Michal Preminger
HEAD, JOHNSON & JOHNSON INNOVATION, EAST NORTH AMERICA, JOHNSON & JOHNSON INNOVATION
Speaking on: Brave Innovations: Public and Private Solutions to Advance Alzheimer’s Therapeutics and Diagnostic in a Risk-Averse Climate and Derisking Early Research and Increasing Likelihood of Clinical Success
William Simmons
SENIOR PATENT COUNCEL, JOHNSON & JOHNSON
Speaking on: AI Innovations: To Patent or Not to Patent?
Paul Stoffels, MD
VICE CHAIRMAN OF THE EXECUTIVE COMMITTEE AND CHIEF SCIENTIFIC OFFICER, JOHNSON & JOHNSON
Speaking on: A Way Forward: Winning the War on COVID through Vaccines
Joanne Waldstreicher, MD
CHIEF MEDICAL OFFICER, JOHNSON & JOHNSON
Speaking on: Bioethics Through the Lens of a Pandemic
Margaret Yu, MD
VICE PRESIDENT, DISEASE AREA LEADER, PROSTATE AT THE JANSSEN PHARMACEUTICAL COMPANIES OF JOHNSON & JOHNSON
Speaking on: What Was Hot at ASCO 2020? Highlights from the World’s Biggest Oncology Meeting
And don't forget to meet Johnson & Johnson in BIO One-on-One Partnering during BIO Digital Week!
